The Double-Edged Sword of Epidermal Growth Factor Receptor Inhibitor: Rash as Toxicity and Prognostic Marker

June 2026 in “ Indian Journal of Postgraduate Dermatology ”

Anuja Yadav, Ankur Sharma, Niharika Singh, Sonika Garg

This study is being processed and will be analyzed soon.

View this study on ijpgderma.org →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community Anagenic is trying to compound Gt20029

in Treatment 56 upvotes 3 years ago

The conversation discusses concerns that Anagenic's version of GT20029 might not be as effective or safe as Kintor's, with comparisons to issues faced by pyrilutamide. The chemical structure of the drug has been published.

community Red and ichy pimples/rash from applying topical minoxidil

in Chat 2 upvotes 5 months ago

The user experienced red pimples and a rash from using topical minoxidil, possibly due to propylene glycol. Suggestions included seeing a dermatologist, switching to foam without propylene glycol, using Nizoral, and adjusting application timing.

community GT20029 - Promising phase II results

in Research/Science 15 upvotes 2 years ago

GT20029 showed significant hair growth and safety in phase II trials, with no adverse sexual events. Users are hopeful but concerned about future costs and systemic effects.

community Does applying Epidermal Growth Factor (EGF) make a difference in hair growth?

in Treatment 4 upvotes 3 years ago

Applying Epidermal Growth Factor (EGF) topically may improve skin and potentially promote scalp health and hair growth, especially after microneedling. The user shares their positive experience with EGF and provides a product link.

community Ru58841 made my hair worse

in General 138 upvotes 1 year ago

RU58841 worsened hair condition, causing thinning and unusual patterns. The user stopped using it two months ago but hasn't seen recovery, and there's speculation about androgen receptor upregulation.

community Setipiprant/PGE2 feedbacks?

in Question 4 upvotes 8 years ago

The conversation discusses using PGE2 as a hair growth stimulant, comparing it to minoxidil, and considering the addition of Setipiprant. Concerns about side effects like skin damage and cost are also mentioned.

Similar Research

5 / 1000+ results

research Rash from EGFR inhibitors: Opportunities and challenges for palliation

18 citations , July 2008 in “Current Oncology Reports”

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

research Skin reactions caused by epidermal growth factor receptor inhibitors and their management

November 2010 in “International Journal of Dermatology and Venereology”

EGFR inhibitors can cause skin issues, and managing these is important for treatment success.

research Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management

68 citations , January 2014 in “Dermatology research and practice”

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

research Management of Dermatologic Toxicities

12 citations , May 2015 in “Journal of the National Comprehensive Cancer Network”

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

research Advances in the Management of Cutaneous Toxicities of Targeted Therapies

42 citations , April 2012 in “Seminars in Oncology”

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.